Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.16872 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Anticancer Research, 2024. Verfasst von Hiroomi Ogawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan; hiroo…. Hauptthemen laut MEDLINE: Chemotherapy, Adjuvant, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan; hiroomio@gunma-u.ac.jp.
- Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of Surgery, Takasaki General Medical Center, Takasaki, Japan.
- General Surgery, Japan Red Cross Maebashi Hospital, Maebashi, Japan.
- Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Zitieren
APA
Ogawa, H., Shiraishi, T., Okada, T., Miyamae, Y., Motegi, Y., Shirabe, K., & Saeki, H. (2024). Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16872
Vancouver
Ogawa H, Shiraishi T, Okada T, Miyamae Y, Motegi Y, Shirabe K, et al. Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16872
BibTeX
@article{Ogawa2024,
author = {Ogawa, Hiroomi and Shiraishi, Takuya and Okada, Takuhisa and Miyamae, Yohei and Motegi, Yoko and Shirabe, Ken and Saeki, Hiroshi},
title = {Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16872}
}
EUVIMED